Mashup Score:5101
Centers for Disease Control and Preve...COVID Data Tracker - 1 week
Mashup Score:5101
Twitter Feed: Eric Topol
Mashup Score:522
NatureThe post-acute sequelae of COVID-19 present major problems for many patients, their physicians and the health-care system. They are unrelated to the severity of...
-
New and succinct review of postural orthostatic tachycardia syndrome (POTS) and autonomic dysfunction post-acute Covid https://t.co/Y6NHGkKTHV #LongCovid @ArturFedorowski @NatRevCardiol https://t.co/Y6NHGkKTHV - view on twitter
More coverage:
#longcovid
Mashup Score:395
erictopol.substack.comEngineering T cells - 1 week
Mashup Score:395
Exciting recent advances in cancer, autoimmune conditions, reversal of scarring and...
-
Some years ago, owing to the formidable and practical challenges, I thought the chance for T cell therapy to make a difference would be minimal. That's changing. https://t.co/2m7WF34Pj3 - view on twitter
Mashup Score:317
NatureThe next generation of coronavirus vaccines: a graphical guide - 6 days
Mashup Score:317
New technologies might provide more potent or broader immunity — but will have to fight for market...
-
The future of Covid vaccines that we need now, a new feature @Nature by @ewencallaway, including nasal, for mucosal immunity, and universal, more durable, variant-proof ones with less side effects https://t.co/9U5xO2Ve1B https://t.co/9U5xO2Ve1B - view on twitter
Mashup Score:267
erictopol.substack.comEngineering T cells - 1 week
Mashup Score:267
Exciting recent advances in cancer, autoimmune conditions, reversal of scarring and...
-
I wrote about the remarkable, multi-dimensional progress that we've been seeing recently for engineering T cells to address refractory medical conditions https://t.co/2m7WF34Pj3 - view on twitter
Mashup Score:267
The LancetWhen dignity meets evidence - 5 days
Mashup Score:267
We are all entitled to dignity because we possess certain ethically important features. One of those human features is that we are knowers. We...
-
Dignity-based medicine "Respecting the dignity of the patient as a knower suggests that expertise should also include the expertise of patients—on their body, their experience of pain or joy, and how they weight the risk of harm against benefit" https://t.co/UgyNum3j5q https://t.co/UgyNum3j5q - view on twitter
Mashup Score:263
New York TimesWho Should Get a Covid Booster Now? New Data Offers Some Clarity. - 5 days
Mashup Score:263
If you are high-risk, the answer is straightforward. If you are low-risk, there is less...
-
Good new rundown on bivalent booster benefit https://t.co/mGmGjb0e3s by @SmithDanaG @NYTHealth https://t.co/mGmGjb0e3s - view on twitter
Background: Unlike intramuscular vaccines, intranasal COVID-19 vaccines may generate mucosal immunity, which may be critical for to prevent infection and...
-
The 1st results for the @BharatBiotech nasal vaccine (BBV154, approved in India) randomized trial vs shots now posted, superior antibody and cellular immune response (vs ancestral and Omicron); 4-fold less side effects https://t.co/2NlUbIiJau https://t.co/2NlUbIiJau - view on twitter
Mashup Score:229
MedscapeWhite House COVID Chief on Why Paxlovid Is Underused - 7 days
Mashup Score:229
Giving Paxlovid to an older adult with COVID is a clinical no-brainer. So why is there so much Paxlovid prescribing...
-
My interview with @AshishKJha46, leader of the @WHCOVIDResponse, about the pandemic We covered many important issues🧵 https://t.co/dzSNMOCQRH 1. Underuse of Paxlovid in older patients: not backed up by low incidence of rebound and ease of sidestepping potential drug interactions - view on twitter
Mashup Score:226
NatureTime of day shapes the success of a cancer treatment - 6 days
Mashup Score:226
Circadian rhythms influence immune cells and a vaccination...
-
How the time of day may affect cancer treatment https://t.co/i7ur2E83df @Nature @NatureNV https://t.co/i7ur2E83df - view on twitter
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use...
Updated @CDCgov data on bivalent booster, age groups and deaths Overall 91% reduction of deaths across all age groups vs unvaccinated, less (80%) without bivalent booster The absolute reduction increases w/ age; relative reduction is consistent across ages https://t.co/HGyjNwUveD https://t.co/HGyjNwUveD - view on twitter